These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8192455)

  • 1. Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Brajtburg J; Elberg S; Travis SJ; Kobayashi GS
    Antimicrob Agents Chemother; 1994 Feb; 38(2):294-9. PubMed ID: 8192455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Ramos H; Brajtburg J; Marquez V; Cohen BE
    Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.
    Brajtburg J; Elberg S; Kobayashi GS; Bolard J
    Antimicrob Agents Chemother; 1994 Feb; 38(2):300-6. PubMed ID: 8192456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
    J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.
    Joly V; Farinotti R; Saint-Julien L; Chéron M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1994 Feb; 38(2):177-83. PubMed ID: 8192439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy evaluation of a novel submicron amphotericin B emulsion in murine candidiasis.
    Levy MY; Polacheck I; Barenholz Y; Benita S
    J Med Vet Mycol; 1993; 31(3):207-18. PubMed ID: 8360812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier effects on biological activity of amphotericin B.
    Brajtburg J; Bolard J
    Clin Microbiol Rev; 1996 Oct; 9(4):512-31. PubMed ID: 8894350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.
    Falk R; Domb AJ; Polacheck I
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1975-81. PubMed ID: 10428922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome).
    Adler-Moore JP; Chiang SM; Satorius A; Guerra D; McAndrews B; McManus EJ; Proffitt RT
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():63-71. PubMed ID: 1778893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.
    Saint-Julien L; Joly V; Seman M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2722-8. PubMed ID: 1482139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
    Brime B; Molero G; Frutos P; Frutos G
    Eur J Pharm Sci; 2004 Aug; 22(5):451-8. PubMed ID: 15265515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice.
    van Etten EW; Snijders SV; van Vianen W; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2431-3. PubMed ID: 9736577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micelles.
    Brajtburg J; Elberg S; Kobayashi GS; Medoff G
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2415-6. PubMed ID: 2088196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
    Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
    Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.
    Gondal JA; Swartz RP; Rahman A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1544-8. PubMed ID: 2684010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis.
    Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):899-902. PubMed ID: 9559804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
    Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
    Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.